摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[2-N-[2-(trimethylsilyl)ethoxycarbonyl]pteroyl]imidazole | 292045-48-8

中文名称
——
中文别名
——
英文名称
1-[2-N-[2-(trimethylsilyl)ethoxycarbonyl]pteroyl]imidazole
英文别名
(6-([4-(imidazol-1-ylcarbonyl)phenylamino]methyl)-4-oxo-3,4-dihydro-pteridin-2-yl)-carbamic acid 2-trimethylsilylethyl ester;1-[2-[2-(trimethylsilyl)ethoxycarbonyl]pteroyl]-imidazole;1-[2-N-[2-(trimethylsilyl)ethoxycarbonyl]pteroyl]-imidazole;2-trimethylsilylethyl N-[6-[[4-(imidazole-1-carbonyl)anilino]methyl]-4-oxo-3H-pteridin-2-yl]carbamate
1-[2-N-[2-(trimethylsilyl)ethoxycarbonyl]pteroyl]imidazole化学式
CAS
292045-48-8
化学式
C23H26N8O4Si
mdl
——
分子量
506.596
InChiKey
NCXWLNDBFDXSBG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    36
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    153
  • 氢给体数:
    3
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Process for producing folic acid derivatives
    申请人:Kataoka Kazunori
    公开号:US20070142387A1
    公开(公告)日:2007-06-21
    This invention provides a process for efficient production of folic acid derivatives suitable for forming conjugates of anticancer drug with folic acid. It discloses a process comprising a step of reacting 2-amino-protected pteroylimidazole with γ-lower alkyl glutamate; and a step of reacting the resulting product with an amino compound having a reactive group which is readily reactable with a functional group of the drug.
    该发明提供了一种高效生产适合与叶酸形成抗癌药物偶联物的叶酸衍生物的方法。其中包括反应2-氨基保护的叶酸咪唑与γ-低烷基谷氨酸的步骤,以及反应所得产物与具有与药物的功能基易于反应的反应性基团的氨基化合物的步骤。
  • Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles
    作者:Eleonora Colombo、Davide Andrea Coppini、Simone Maculan、Pierfausto Seneci、Benedetta Santini、Filippo Testa、Lucia Salvioni、Giovanni Maria Vanacore、Miriam Colombo、Daniele Passarella
    DOI:10.1039/d2ra06306a
    日期:——
    Hetero-nanoparticles self-assembled from a conjugate bearing folic acid as the targeting agent, and another bearing paclitaxel as the active agent are reported. Hetero-nanoparticles containing varying percentages of folic acid conjugates are characterised, and their biological activity is determined.
    报道了由以叶酸为靶向剂的缀合物和另一种以紫杉醇为活性剂的缀合物自组装的杂纳米颗粒。表征了含有不同百分比的叶酸缀合物的杂纳米颗粒,并确定了它们的生物活性。
  • Cryptophane-Folate Biosensor for <sup>129</sup>Xe NMR
    作者:Najat S. Khan、Brittany A. Riggle、Garry K. Seward、Yubin Bai、Ivan J. Dmochowski
    DOI:10.1021/bc5005526
    日期:2015.1.21
    Folate-conjugated cryptophane was developed for targeting cryptophane to membrane-bound folate receptors that are overexpressed in many human cancers. The cryptophane biosensor was synthesized in 20 nonlinear steps, which included functionalization with folate recognition moiety, solubilizing peptide, and Cy3 fluorophore. Hyperpolarized Xe-129 NMR studies confirmed xenon binding to the folate-conjugated cryptophane. Cellular internalization of biosensor was monitored by confocal laser scanning microscopy and quantified by flow cytometry. Competitive blocking studies confirmed cryptophane endocytosis through a folate receptor-mediated pathway. Flow cytometry revealed 10-fold higher cellular internalization in KB cancer cells overexpressing folate receptors compared to HT-1080 cells with normal folate receptor expression. The biosensor was determined to be nontoxic in HT-1080 and KB cells by MTT assay at low micromolar concentrations typically used for hyperpolarized Xe-129 NMR experiments.
  • EP1734044
    申请人:——
    公开号:——
    公开(公告)日:——
  • Regioselective synthesis of folic acid conjugates from diether-type archaeal lipid analogues
    作者:Céline Lainé、Clémence Mocquet、Loïc Lemiègre、Thierry Benvegnu
    DOI:10.1016/j.tet.2008.12.013
    日期:2009.2
    A regioselective access to both alpha- and gamma-folic acid conjugates derived from archaeal lipid analogues is described. The synthetic approach is based on conveniently protected glutamates that led first to alpha- and gamma-glutamate derivatives. The final reconstruction of the folic acid moiety was achieved through the reaction of a protected/activated pteroate followed by a simple deprotection step. These alpha- and gamma-folic acid conjugates Would permit to establish the importance of a regiocontrolled introduction of folic acid on the folic acid/folate receptor interaction in the case of a targeted drug/gene delivery. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多